Page last updated: 2024-08-24

gemcitabine and Neoplasm Metastasis, Unknown Primary

gemcitabine has been researched along with Neoplasm Metastasis, Unknown Primary in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.33)18.2507
2000's19 (63.33)29.6817
2010's10 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, W; Jiang, W; Liu, L; Ma, R; Peng, L; Tong, Z; Wang, K; Wang, L; Wu, L; Wu, W; Yao, M; Zhang, H; Zhao, P; Zheng, Y1
Chan, KS; Lim, KH; Lim, WT; Lynette, O; Montoya, J; Ng, QS; Sakktee Krisna, S; Takano, A; Tan, DS; Tan, EH1
Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Sycova-Mila, Z1
Kord Valeshabad, A; Mieler, WF; Setlur, V; Shahidi, M; Thomas, M1
Al-Batran, SE; Aldaoud, A; Bernhard, H; Burkart, C; Folprecht, G; Hoffmann, M; Huebner, G; Jahn, A; Kaiser, U; Kohne, CH; Kretzschmar, A; Kullmann, F; Link, H; Menges, M; Otremba, B; Schoffski, P; Stahl, M; Steinbach, S1
Ikeda, H; Mouri, H; Nakanuma, Y; Ohtsubo, K; Tsuchiyama, T; Watanabe, H; Yamada, T; Yamashita, K; Yano, S; Yasumoto, K1
Isik, M; Kos, FT; Odabas, H; Seker, MM; Uncu, D; Zengin, N1
Daugaard, G; Gothelf, A; Møller, AK; Pedersen, KD1
Chaudhary, RT; Li, G; Saikumar, J1
Carlson, H; Lenzi, R; Raber, MN; Varadhachary, GR1
Blot, E; Bouzy, J; Chaigneau, L; Culine, S; Fizazi, K; Fourcade, A; Gross-Goupil, M; Kaminsky, MC; Laplanche, A; Lesimple, T; Lortholary, A; Négrier, S; Penel, N; Priou, F; Provencal, J; Voog, E1
Ames, MM; Behrens, RJ; Erlichman, C; Foster, NR; Goetz, MP; Graham, DL; Holtan, SG; Medeiros, F; Safgren, SL; Steen, PD1
Green, MR; Leong, SS; Perkel, JA; Putman, T; Rocha Lima, CM; Safa, AR; Sherman, CA1
André, T; Culine, S; Epaud, C; Gligorov, J1
Abad, A; Balaña, C; Cirauqui, B; Font, A; Manzano, JL; Mate, JL; Moreno, I; Rosell, R1
Allouache, J; Bouzy, J; Bugat, R; Coudert, B; Culine, S; Douillard, JY; Fizazi, K; Goupil, A; Kaminsky, MC; Laplanche, A; Lesimple, T; Lortholary, A; Merrouche, Y; Négrier, S; Petrow, P; Pivot, X; Priou, F; Théodore, C; Viala, J; Voigt, JJ1
Becht, C; Culine, S; Cupissol, D; Fabbro, M; Pinguet, F; Pouessel, D; Romieu, G; Ychou, M1
Barceló, JR; López-Vivanco, G; Muñoz, A1
Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P1
Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Hermann, R; Litchy, S; Morrissey, LH; Rodriguez, GI; Shaffer, DW; Yardley, DA1
Greco, FA; Hainsworth, JD; Kommor, M; Kuzur, ME; Litchy, S; Raefsky, EL; Spigel, DR; Yost, K1
Chatani, K; Kametani, T; Masuda, S; Shibata, K; Takase, M1
Karapetis, CS; Keefe, DM; Koczwara, B; Kotasek, D; Moldovan, S; Olver, IN; Parnis, FX; Patterson, WK; Pittman, KB; Price, TJ; Yeend, SJ1
Comella, G; Danova, M; Ferraú, F; Lorusso, V; Massidda, B; Nortilli, R; Palmeri, L; Palmeri, S; Porta, C; Vaglica, M1
El-Rayes, B; Griffith, KA; Kalemkerian, GP; Muler, JH; Philip, PA; Schneider, BJ; Zalupski, MM1
Atzpodien, J; Fluck, M; Reitz, M; Terfloth, K1
Adjei, AA; Erlichman, C1
Bhupalam, L; Fleming, DR; Glisson, SD; Goldsmith, GH; LaRocca, RV; Michelson, GD1
Bramham, J; Burris, HA; Calvert, SW; Greco, FA; Hainsworth, JD; Scullin, DC; Willcutt, NT1
Barton, JH; Bradof, JE; Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Litchy, S; Morrissey, LH; Richards, P; Scullin, DC1

Reviews

1 review(s) available for gemcitabine and Neoplasm Metastasis, Unknown Primary

ArticleYear
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Rate

2012

Trials

19 trial(s) available for gemcitabine and Neoplasm Metastasis, Unknown Primary

ArticleYear
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.
    British journal of cancer, 2009, Jan-13, Volume: 100, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; ErbB Receptors; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Proportional Hazards Models; Prospective Studies; Vinblastine; Vinorelbine

2009
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Risk Factors; Treatment Outcome

2010
A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary.
    International journal of clinical oncology, 2013, Volume: 18, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Unknown Primary; Organoplatinum Compounds; Oxaliplatin

2013
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Rate

2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Cohort Studies; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Treatment Outcome

2012
Irinotecan and gemcitabine in patients with solid tumors: phase I trial.
    Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:5 Suppl 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Diarrhea; Gemcitabine; Hematologic Diseases; Humans; Irinotecan; Maximum Tolerated Dose; Nausea; Neoplasms; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Vomiting

2002
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary

2003
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary

2003
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.
    Cancer, 2004, Mar-15, Volume: 100, Issue:6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasms, Unknown Primary; Survival Analysis; Taxoids; Treatment Outcome

2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
    The oncologist, 2004, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome

2004
Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.
    Cancer, 2005, Nov-01, Volume: 104, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Deoxycytidine; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Analysis; Treatment Outcome

2005
Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study.
    British journal of cancer, 2006, Nov-20, Volume: 95, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Carcinoma, Large Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome

2006
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
    Cancer, 2006, Dec-15, Volume: 107, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Injections, Intravenous; Italy; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Vinblastine; Vinorelbine

2006
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
    Cancer, 2007, Aug-15, Volume: 110, Issue:4

    Topics: Abdominal Neoplasms; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Carcinoembryonic Antigen; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome

2007
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
    British journal of cancer, 2007, Nov-19, Volume: 97, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Recurrence; Remission Induction; Skin Neoplasms; Survival Rate; Treatment Outcome

2007
A phase I trial of MTA and gemcitabine in patients with locally advanced or metastatic cancer.
    Seminars in oncology, 1999, Volume: 26, Issue:2 Suppl 6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gallbladder Neoplasms; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Pemetrexed

1999
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
    American journal of clinical oncology, 2000, Volume: 23, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Deoxycytidine; Diarrhea; Esophageal Neoplasms; Exanthema; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Paresthesia; Urinary Bladder Neoplasms; Vomiting

2000
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.
    Cancer investigation, 2001, Volume: 19, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Salvage Therapy; Thrombocytopenia; Treatment Outcome

2001
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-15, Volume: 20, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome

2002

Other Studies

11 other study(ies) available for gemcitabine and Neoplasm Metastasis, Unknown Primary

ArticleYear
Carcinoma of Unknown Primary with
    The oncologist, 2019, Volume: 24, Issue:4

    Topics: Adult; Anaplastic Lymphoma Kinase; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Deoxycytidine; Female; Gemcitabine; High-Throughput Nucleotide Sequencing; Humans; Neoplasms, Unknown Primary; Oncogene Proteins, Fusion; Prognosis

2019
Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Biopsy; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Gefitinib; Gemcitabine; Humans; Immunohistochemistry; Leucine; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Neoplasms, Unknown Primary; Point Mutation; Quinazolines; Tomography, X-Ray Computed

2013
The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Slovakia; Survival Analysis; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine

2014
Posterior segment toxicity after gemcitabine and docetaxel chemotherapy.
    Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Neoplasm Staging; Neoplasms, Unknown Primary; Photoreceptor Cells, Vertebrate; Sarcoma; Taxoids; Tomography, Optical Coherence; Uveal Diseases; Vision Disorders; Visual Acuity

2015
Cancer of unknown primary site in which tumor marker-oriented chemotherapy was effective and pancreatic cancer was finally confirmed at autopsy.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:18

    Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms

2009
Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies

2011
Reversible neuropathy after chemotherapy for metastatic adenocarcinoma from an unknown primary tumor to the sural nerve.
    American journal of therapeutics, 2011, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Peripheral Nervous System Neoplasms; Polyneuropathies; Sural Nerve

2011
[Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
    Bulletin du cancer, 2002, Volume: 89 Spec No

    Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunotherapy; Lung Neoplasms; Mitomycins; Multicenter Studies as Topic; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Pemetrexed; Radiotherapy; Remission Induction; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine

2002
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.
    Cancer, 2004, Aug-01, Volume: 101, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Neoplasm Staging; Neoplasms, Unknown Primary; Prognosis; Risk Assessment; Survival Rate; Taxoids; Treatment Outcome

2004
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
    BMC cancer, 2004, Nov-23, Volume: 4

    Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gefitinib; Gemcitabine; Humans; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quinazolines; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Uveal Neoplasms

2004
[A case of adenocarcinoma of unknown primary site successfully treated with gemcitabine monotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10

    Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Pleural Effusion, Malignant; Tomography, X-Ray Computed

2006